pargyline has been researched along with Autoimmune Disease in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeleń, M | 1 |
| Pluta, K | 1 |
| Zimecki, M | 1 |
| Morak-Młodawska, B | 1 |
| Artym, J | 1 |
| Kocięba, M | 1 |
| Kochanowska, I | 1 |
1 other study available for pargyline and Autoimmune Disease
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel propargylquinobenzothiazines and their derivatives as potential antiproliferative, anti-inflammatory, and anticancer agents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Autoimmune Diseases; Cell Line, Tumo | 2016 |